Home Cart 0 Sign in  
X

[ CAS No. 112-39-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 112-39-0
Chemical Structure| 112-39-0
Chemical Structure| 112-39-0
Structure of 112-39-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 112-39-0 ]

Related Doc. of [ 112-39-0 ]

Alternatived Products of [ 112-39-0 ]

Product Details of [ 112-39-0 ]

CAS No. :112-39-0 MDL No. :MFCD00008994
Formula : C17H34O2 Boiling Point : -
Linear Structure Formula :- InChI Key :FLIACVVOZYBSBS-UHFFFAOYSA-N
M.W : 270.45 Pubchem ID :8181
Synonyms :
Methyl hexadecanoate;Palmitic acid methyl ester;C16:0 Methyl ester
Chemical Name :Palmitic Acid Methyl Ester

Calculated chemistry of [ 112-39-0 ]

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.94
Num. rotatable bonds : 15
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 85.12
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -2.71 cm/s

Lipophilicity

Log Po/w (iLOGP) : 4.41
Log Po/w (XLOGP3) : 7.38
Log Po/w (WLOGP) : 5.64
Log Po/w (MLOGP) : 4.44
Log Po/w (SILICOS-IT) : 5.84
Consensus Log Po/w : 5.54

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 1.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.18
Solubility : 0.0018 mg/ml ; 0.00000667 mol/l
Class : Moderately soluble
Log S (Ali) : -7.76
Solubility : 0.00000468 mg/ml ; 0.0000000173 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -6.01
Solubility : 0.000264 mg/ml ; 0.000000975 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 2.53

Safety of [ 112-39-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 112-39-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 112-39-0 ]
  • Downstream synthetic route of [ 112-39-0 ]

[ 112-39-0 ] Synthesis Path-Upstream   1~13

  • 1
  • [ 112-39-0 ]
  • [ 50-81-7 ]
  • [ 137-66-6 ]
Reference: [1] Synthetic Communications, 2009, vol. 39, # 7, p. 1143 - 1151
  • 2
  • [ 67-56-1 ]
  • [ 8001-22-7 ]
  • [ 14663-11-7 ]
  • [ 88400-02-6 ]
  • [ 10030-74-7 ]
  • [ 112-62-9 ]
  • [ 112-63-0 ]
  • [ 1120-34-9 ]
  • [ 2733-88-2 ]
  • [ 124-10-7 ]
  • [ 112-39-0 ]
  • [ 1731-92-6 ]
  • [ 112-61-8 ]
  • [ 1120-28-1 ]
  • [ 929-77-1 ]
  • [ 2442-49-1 ]
  • [ 10305-59-6 ]
  • [ 37929-05-8 ]
  • [ 56-81-5 ]
Reference: [1] Patent: WO2007/12190, 2007, A1, . Location in patent: Page/Page column 16-18
  • 3
  • [ 67-56-1 ]
  • [ 14663-11-7 ]
  • [ 88400-02-6 ]
  • [ 10030-74-7 ]
  • [ 112-62-9 ]
  • [ 112-63-0 ]
  • [ 1120-34-9 ]
  • [ 2733-88-2 ]
  • [ 124-10-7 ]
  • [ 112-39-0 ]
  • [ 1731-92-6 ]
  • [ 112-61-8 ]
  • [ 1120-28-1 ]
  • [ 929-77-1 ]
  • [ 2442-49-1 ]
  • [ 10305-59-6 ]
  • [ 37929-05-8 ]
  • [ 56-81-5 ]
Reference: [1] Patent: WO2007/12190, 2007, A1, . Location in patent: Page/Page column 13-15
  • 4
  • [ 67-56-1 ]
  • [ 14663-11-7 ]
  • [ 88400-02-6 ]
  • [ 10030-74-7 ]
  • [ 112-62-9 ]
  • [ 112-63-0 ]
  • [ 1120-34-9 ]
  • [ 2733-88-2 ]
  • [ 124-10-7 ]
  • [ 112-39-0 ]
  • [ 1731-92-6 ]
  • [ 112-61-8 ]
  • [ 1120-28-1 ]
  • [ 929-77-1 ]
  • [ 2442-49-1 ]
  • [ 10305-59-6 ]
  • [ 37929-05-8 ]
  • [ 56-81-5 ]
Reference: [1] Patent: WO2007/12190, 2007, A1, . Location in patent: Page/Page column 10-12
  • 5
  • [ 112-62-9 ]
  • [ 124-07-2 ]
  • [ 112-05-0 ]
  • [ 2104-19-0 ]
  • [ 112-39-0 ]
  • [ 112-61-8 ]
Reference: [1] Patent: US2012/302778, 2012, A1, . Location in patent: Page/Page column 4
  • 6
  • [ 112-39-0 ]
  • [ 2536-35-8 ]
Reference: [1] Chemische Berichte, 1942, vol. 75, p. 294
[2] Patent: CH202420, 1937, ,
  • 7
  • [ 112-39-0 ]
  • [ 141-43-5 ]
  • [ 544-31-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 17, p. 5255 - 5257
[2] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 2, p. 340 - 347
[3] ChemSusChem, 2015, vol. 8, # 16, p. 2670 - 2680
  • 8
  • [ 112-39-0 ]
  • [ 629-62-9 ]
  • [ 34557-54-5 ]
  • [ 544-76-3 ]
  • [ 14852-31-4 ]
  • [ 36653-82-4 ]
  • [ 629-80-1 ]
  • [ 540-10-3 ]
  • [ 201230-82-2 ]
  • [ 57-10-3 ]
Reference: [1] RSC Advances, 2016, vol. 6, # 36, p. 30372 - 30383
  • 9
  • [ 112-39-0 ]
  • [ 629-62-9 ]
  • [ 34557-54-5 ]
  • [ 544-76-3 ]
  • [ 14852-31-4 ]
  • [ 36653-82-4 ]
  • [ 629-80-1 ]
  • [ 540-10-3 ]
  • [ 124-38-9 ]
  • [ 201230-82-2 ]
  • [ 57-10-3 ]
Reference: [1] RSC Advances, 2016, vol. 6, # 36, p. 30372 - 30383
  • 10
  • [ 112-39-0 ]
  • [ 36653-82-4 ]
  • [ 629-80-1 ]
  • [ 502-73-8 ]
  • [ 540-10-3 ]
  • [ 57-10-3 ]
Reference: [1] Applied Catalysis A: General, 2016, vol. 526, p. 183 - 190
  • 11
  • [ 112-39-0 ]
  • [ 127-47-9 ]
  • [ 79-81-2 ]
YieldReaction ConditionsOperation in experiment
96% With sodium hydroxide In methanol at 55℃; for 3 h; Large scale To 3000 kg of the compound of formula (la) which is known as Vitamin A acetate, in its crystalline form, 2750 kg of compound of formula (I la) which is known as methyl palmitate have been added. Afterwards 10 kg of NaOH have been dissolved in about 60 I of methanol, which was then added to the mixture of Vitamin A acetate and methyl palmitate. This reaction mixture was heated up to 55°C and the pressure was reduced to about 1500 - 2200 Pa. The reaction time was about 3 hours. During this process the main side product (methyl acetate) was removed continuously by distillation. The reaction was stopped by the addition of water and CO2. Afterwards the compound of formula (Ilia) which is known as Vitamin A palmitate was isolated from the reaction solution by extraction. The yield of compound of formula (Ilia) was 96percent.
Reference: [1] Patent: WO2014/23772, 2014, A1, . Location in patent: Page/Page column 9
  • 12
  • [ 112-39-0 ]
  • [ 68-26-8 ]
  • [ 79-81-2 ]
YieldReaction ConditionsOperation in experiment
94% at 60℃; for 3 h; Large scale 3.28 kg of vitamin A acetate and 16.5 g of potassium methoxide were added to 33 L of methanol under nitrogen protection, and the reaction was carried out at 30 ° C for about 3hour;After completion of the reaction, it was concentrated to dryness under reduced pressure at 40 ° C to give a yellow oil as a vitamin A alcohol.The obtained vitamin A alcohol was mixed with 2.80 kg of methyl palmitate.The mixture was heated to 60 ° C and then the pressure was reduced to about 100 Pa for about 3 hours.The reaction was terminated by nitrogen gas, and 20 L of n-hexane and 165 g of activated carbon were added.After decolorizing for 30 minutes, the silica gel was filtered, and the filtrate was concentrated to dryness under reduced pressure.A pale yellow oil of 4.93 kg was obtained with a yield of 94percent.The obtained oil was analyzed according to the method of the United States Pharmacopoeia USP28, and the result showed that the purity of vitamin A palmitate was 1.77 million IU/g.
Reference: [1] Patent: CN108623507, 2018, A, . Location in patent: Paragraph 0017-0028
  • 13
  • [ 67-56-1 ]
  • [ 112-39-0 ]
  • [ 473-98-3 ]
Reference: [1] Chemical and pharmaceutical bulletin, 2003, vol. 51, # 1, p. 89 - 91
Same Skeleton Products
Historical Records